Extracapsular spread (ECS) of cervical lymph node metastases from squamous cell carcinoma of the head and neck (HNSCC) has a strong negative effect on patient prognosis. Cervical lymph node metastases alone predict reduced survival and increased disease recurrence.
1-3 Compared with patients having disease confined to the lymph nodes, the presence of ECS in patients having regional neck disease dramatically decreases 5-year survival from 70% to 27%.
4 Significant increases in the rates of locoregional recurrence and distant metastases have been associated with ECS.
5,6 It has been suggested that ECS is the single most important prognostic marker for recurrence and survival in patients with HNSCC.
7,8